Non-steroidal anti-inflammatory drug and analgesic intake between months 0 and 36 in the full analysis set
| Clinical outcome changes between months 0 and 36 | Placebo (n=179) | ASU-E (n=166) | p Value |
|---|---|---|---|
| NSAID/analgesic intake (n (%) of patients who had at least one intake of an NSAID or analgesic during the trial) | 157 (87.7) | 145 (87.3) | 0.919 |
| NSAID intake (n (%) of patients who had at least 1 intake during the trial) | 115 (64.2) | 109 (65.7) | 0.783 |
ASU-E, avocado–soybean unsaponifiable—Expanscience; NSAID, non-steroidal anti-inflammatory drug.